F. Montravers et al., IN-VIVO INACCESSIBILITY OF SOMATOSTATIN RECEPTORS TO IN-111-PENTREOTIDE IN PRIMARY RENAL-CELL CARCINOMA, Nuclear medicine communications, 19(10), 1998, pp. 953-961
The presence of somatostatin receptors on human renal cell carcinomas
in surgically removed kidneys has been demonstrated by autoradiography
. The aim of this study was to detect the in vivo presence of somatost
atin receptors in primary renal tumours and their possible metastases
before surgery, using In-111-pentreotide scintigraphy. Tl-201 was used
as a sensitive tumour-seeking agent with blood flow-dependent uptake.
Fifteen patients were imaged before surgical removal of the renal tum
our. Thirteen tumours were malignant. The large tumours (more than 4 c
m in diameter) did not accumulate In-111-pentreotide or Tl-201. In con
trast, the single small tumour accumulated both tracers. A scalp skin
metastasis was demonstrated in one patient by Tl-201 and In-111-pentre
otide uptake. In one case, known lung metastases were visualized with
both Tl-201 and In-111-pentreotide, but the lung metastases of another
three patients as well as one case of epidural metastasis were not id
entified. In one patient with a photopaenic lesion, positive labelling
of the surgically removed tumour was demonstrated by in vitro autorad
iography. Somatostatin receptor scintigraphy with In-111-pentreotide a
ppears to have Little value for the detection of metastases in patient
s with renal cell carcinoma, as some metastases (especially those of t
he lungs) were missed. The absence of In-111-pentreotide uptake by lar
ge primary tumours is an interesting finding, suggesting inaccessibili
ty of these very large tumours to drugs. ((C) 1998 Lippincott Williams
& Wilkins).